Eszopiclone didn't improve tumors in a very p53 transgenic mouse bioassay at oral doses around three hundred mg/kg/day. Mutagenesis Eszopiclone was clastogenic in in vitro (mouse lymphoma and chromosomal aberration) assays in mammalian cells. Eszopiclone was adverse during the in vitro bacterial gene mutation (Ames) assay As well as in https://valeriusk530hov6.webbuzzfeed.com/profile